Open AccessThe Recent Updates on Approaches and Clinical Trials Status of Covid-19 Vaccines Developed Globally
Author(s) -
Sachin Chaudhary,
AbdelNasser ElShorbagi,
Ramesh K. Gupta,
Amit Kumar
Publication year - 2021
Publication title -
biomedical and pharmacology journal/biomedical and pharmacology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.191
H-Index - 18
eISSN - 2456-2610
pISSN - 0974-6242
DOI - 10.13005/bpj/2214
Subject(s) - pandemic , covid-19 , safer , virology , clinical trial , outbreak , medicine , dna vaccination , immunization , immunology , computer science , disease , computer security , infectious disease (medical specialty) , pathology , antigen
The Covid-19 pandemic since 2019 has imparted a massive influence on the human life around the world, irrespective of all the precautionary measures followed worldwide it is strongly suggested that only the effective and safer vaccine can control this vicious pandemic. Nevertheless, the vaccine development strategies for Covid-19 was initiated firstly in china after the outbreak of Covid-19 and then globally after it was declared as pandemic by World Health Organization. Currently, numerous platforms have been designed for developing the most efficacious and safe vaccines designed by different technologies including protein subunit, viral vector, RNA, DNA, inactivated, and live attenuated approach. Here, this review will illustrates the detailed information on above mentioned Covid-19 vaccines development technologies, protocols and their clinical trial phase status. Additionally, this review also includes the details of vaccines failed to progress further.